Results 271 to 280 of about 137,868 (314)
VaccinesPatients with Type 2 diabetes mellitus (T2DM) and Chronic Kidney Disease (CKD) face an increased risk of morbidity and mortality after influenza infection. Several studies have shown that the influenza vaccine effectively prevents morbidity and mortality in T2DM patients.
Henhen Heryaman +2 more
exaly +5 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Comparative analysis of the transcriptome of T2DM Bama mini-pigs with T2DM patients
International Journal of Diabetes in Developing Countries, 2021To compare the transcriptional differences between the T2DM-susceptible and T2DM-tolerant Bama mini-pigs and to determine the utility of Bama mini-pigs as an animal model for T2DM by comparing the transcriptomes of the animals with T2DM patients. The skeletal muscle transcriptomes of healthy Guangxi Bama mini-pigs (CON), T2DM pigs (T2D), and non-T2DM ...
Xueyu Yan +8 more
openaire +1 more source
Clinical inertia in management of T2DM
Primary Care Diabetes, 2010Diabetes is highly prevalent and serious chronic debilitating disease and reported to be the fourth main cause of death in Europe. Despite extensive evidence of benefits of tight glycemic control, large proportions of people with diabetes do not achieve target glycemic control.
Zafar, A, Davies, M, Azhar, A, Khunti, K
openaire +3 more sources
The pharmacokinetic profiles of mogrosides in T2DM rats
Journal of Ethnopharmacology, 2022Luohanguo (LHG) extract major contenting mogrosides, as a nonnutritive sweetener, has been reported to exert a hypoglycemic effect on diabetic patients and animals. As the pharmacokinetics and pharmacodynamics of drugs were changed with diabetes, it may lead to the different pharmacological of mogrosides between diabetic and normal subjects.To ...
Yulong Zhang +3 more
openaire +2 more sources
SGLT2 inhibitors in people with and without T2DM
Nature Reviews Endocrinology, 2020Heart failure and chronic kidney disease are frequent causes of morbidity and mortality in people with type 2 diabetes mellitus. Cardiovascular outcome trials have confirmed benefits of sodium–glucose co-transporter 2 inhibitors on cardiovascular events, cardiovascular deaths, hospitalization for heart failure and renal outcomes.
openaire +2 more sources
T2DM remission — consensus on definition
Nature Reviews Endocrinology, 2021openaire +2 more sources